Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07078786

Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace

Comparison of Effect of Antenatal Dexamethasone Versus Betamethasone on Antepartum Cardiactocography

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Rawalpindi Medical College · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

As baby grows inside the womb of mother, heart and other organs develop. The heart activity can be recorded by placing a transducer on the belly of mother. The tracing obtain provides information about heart rate, any increase or decrease in heart rate and how much it varies with time. Variation in heart rate along with increase is indicator of fetal well being. Some mothers are at high risk of pre-term birth that is baby delivery before 37 weeks of gestation. In such cases steroids are given to mother to accelerate lung development of the baby so that it can easily adapt to outside world. Dexamethasone and Betamethasone are commonly used steroids which can also effect fetal heart activity.

Detailed description

Some patients are at high risk of Pre term birth and therefore they are advised antenatal steroids which facilitates fetal lung development preparing it for smoother transition for extra-uterine life. Dexamethasone and Betamethasone are commonly used for this purpose but differently effect fetal cardiac activity as evident by CTG changes and awareness of these phenomena would prevent iatrogenic delivery of preterm fetuses.

Conditions

Interventions

TypeNameDescription
DRUGBetamethason Sodium PhosphateIntramuscular injection of Betamethasone 12mg will be administered on 2 consecutive days
DRUGDexamethasonetwo doses of 12mg of IM Dexamethasone given 24 hours apart

Timeline

Start date
2025-07-13
Primary completion
2025-10-15
Completion
2025-10-15
First posted
2025-07-22
Last updated
2025-08-12

Locations

1 site across 1 country: Pakistan

Regulatory

Source: ClinicalTrials.gov record NCT07078786. Inclusion in this directory is not an endorsement.